Login/Sign Up
Tagrisso 80Mg Tablet 10'S
₹128919.5*
MRP ₹151670
15% off
₹128919*
MRP ₹151670
15% CB
₹22751 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
About Tagrisso 80Mg Tablet
Tagrisso 80Mg Tablet belongs to a class of protein kinase inhibitors primarily used to manage or treat lung cancer. Lung cancer is a disease that causes malignant (cancer) cells to grow in lung tissues.
Tagrisso 80Mg Tablet contains Osimertinib, which blocks proteins on cancer cells that encourage cancer growth. Thus, it reduces or stops the progression of advanced cancer.
To treat your condition effectually, continue using Tagrisso 80Mg Tablet for as long as your doctor has prescribed it. The most common adverse reactions are diarrhoea, rash, dry skin, nail toxicity, stomatitis (inflammation of the oral mucosa), fatigue (feeling overtired), decreased appetite, and low blood cell counts. You should talk to your doctor if you persistently experience these side effects.
Before taking the Tagrisso 80Mg Tablet , inform your doctor about all your allergic or hypersensitivity reactions to medicines or food. Tagrisso 80Mg Tablet can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant or get pregnant while undergoing therapy and for several months after the treatment. Using effective contraceptive methods is recommended while on therapy with Tagrisso 80Mg Tablet . Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment. Alcohol should be avoided during treatment with this medicine. Safety and effectiveness in children have not been established.
Uses of Tagrisso 80Mg Tablet
Medicinal Benefits
Tagrisso 80Mg Tablet contains Osimertinib, which belongs to a class of protein kinase inhibitors primarily used to manage or treat lung cancer. Osimertinib blocks proteins in cancer cells that encourage the cancer to grow. Osimertinib can temporarily reduce or stop the progression of advanced cancer. Following surgery, Osimertinib may help prevent the cancer from returning.
Side Effects of Tagrisso 80Mg Tablet
Directions for Use
Storage
Drug Warnings
Before taking the Tagrisso 80Mg Tablet , inform your doctor about all your medical conditions, sensitivities, and medications you are using. Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is required throughout treatment and at least six weeks after treatment for women and four months after treatment for males. You should not breastfeed while taking this medication for two weeks after your last dose. Unless the doctor suggests, do not use any other medicine, including herbal or vitamin supplements. In rare cases, Tagrisso 80Mg Tablet therapy may lead to Interstitial lung disease (ILD)/Pneumonitis. Dyspnea, cough, and fever are the symptoms which may be indicative of ILD. If these symptoms worsen, contact your doctor right away. If ILD is confirmed, your doctor will discontinue the Tagrisso 80Mg Tablet therapy.
Therapeutic Class
Drug Interactions
Drug-Drug Interactions: Tagrisso 80Mg Tablet may interact with medicines used to treat HIV infection (e.g. amprenavir, atazanavir, efavirenz), antibiotics (e.g. erythromycin, gatifloxacin), antidepressants (e.g. escitalopram), immunomodulating medication (e.g. fingolimod), anaesthetics (e.g. halothane) and vaccines (e.g. typhoid vaccine, live, smallpox vaccine, rotavirus vaccine) and antiarrhythmic agent (e.g. quinidine).
Drug-Food Interactions: Avoid the consumption of alcoholic beverages.
Drug-Disease Interactions: Tagrisso 80Mg Tablet interacts with disease conditions, including ILD (Interstitial lung disease)/Pneumonitis (inflammation in your lung tissues without an infection), infections (bacterial/fungal/protozoal/viral), ventricular arrhythmia, arrhythmias, congestive heart failure, dermatitis, ocular infection, pulmonary impairment, fever, renal dysfunction, liver disease.
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
What if I have taken an overdose of Tagrisso 80Mg Tablet
Special Advise
Disease/Condition Glossary
Lung cancer: Lung cancer is one of the most common and serious types of cancer. Lung cancer is a disease that causes malignant (cancer) cells to grow in lung tissues. Primary lung cancer is cancer that begins in the lungs. Secondary lung cancer is cancer that spreads to the lungs from elsewhere in the body. There are usually no signs or symptoms in the early stages of lung cancer. Still, many people experience symptoms such as a chronic cough, coughing up blood, persistent dyspnea, unexplained tiredness and weight loss, and an ache or pain when breathing or coughing.
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Tagrisso 80Mg Tablet .
Pregnancy
Unsafe
Tagrisso 80Mg Tablet should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking these medications.
Breast Feeding
Unsafe
You should not breastfeed for two weeks after your last dose while taking this medication.
Driving
Caution
Tagrisso 80Mg Tablet may cause fatigue (feeling overtired), impacting the ability to drive or use machines.
Liver
Caution
Tagrisso 80Mg Tablet should be used with caution if you have liver disease. Inform your doctor before taking the Tagrisso 80Mg Tablet if you have had a liver impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Tagrisso 80Mg Tablet should be used with caution if you have kidney disease. Inform your doctor before taking the Tagrisso 80Mg Tablet if you have had a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Safety and effectiveness in patients below the age of 18 years have not been established. Hence, use is not recommended.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information